In August 2014, OptiBiotix went public via the reverse takeover of AIM listed investment company Ducat Ventures plc. This transaction brought to market a company active in one of the most progressive areas of biotechnological research, the human microbiome, the collective genome of the microbes in the body, a metabolically active, rapidly renewable ecosystem which is being increasingly linked to host immunity, metabolism and physiology. Advances in our understanding of this enormous gene pool
16 Feb 2015
A gutful of opportunities
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
A gutful of opportunities
OptiBiotix Health PLC (OPTI:LON) | 18.0 0 0.0% | Mkt Cap: 17.6m
- Published:
16 Feb 2015 -
Author:
Derren Nathan -
Pages:
16
In August 2014, OptiBiotix went public via the reverse takeover of AIM listed investment company Ducat Ventures plc. This transaction brought to market a company active in one of the most progressive areas of biotechnological research, the human microbiome, the collective genome of the microbes in the body, a metabolically active, rapidly renewable ecosystem which is being increasingly linked to host immunity, metabolism and physiology. Advances in our understanding of this enormous gene pool